Ceftolozane-tazobactam was non-inferior to levofloxacin for composite cure ( 306 [ 769 % ] of 398 vs 275 [ 684 % ] of 402 , 95 % CI 23-146 ) and , as the lower bound of the two-sided 95 % CI around the treatment difference was positive and greater than zero , superiority was indicated .